Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US approves Medtronic's high-output ICD (implantable cardioverter defibrillator):

This article was originally published in Clinica

Executive Summary

The US FDA has approved Medtronic's high-energy Maximo implantable cardioverter defibrillator (ICD). The ICD delivers 35 joules of energy for patients requiring a bigger shock to regulate their heartbeat. The device, which is available in single or dual chamber models, combines a small size, fast charge times and increased pain-free therapy. With a working life of 8-10 years Maximo is one of the longest-lasting devices on the market, making it very cost-effective, according to the company The RapidRead telemetry feature has also been improved to complete operations in seconds rather than minutes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel